1
|
Assiri AM, Alserehi H, Abuhasan MY, Khalil EAA, Al-Thunayan MH, Alshehri MS, Alrossais AA, Abudahish AS, Alsahafi AJ, Al-Tawfiq JA. Epidemiology, clinical presentation, and outcome of mpox: A study of 381 cases in Saudi Arabia. IJID REGIONS 2024; 11:100358. [PMID: 38590626 PMCID: PMC11000198 DOI: 10.1016/j.ijregi.2024.100358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/22/2024] [Revised: 03/18/2024] [Accepted: 03/19/2024] [Indexed: 04/10/2024]
Abstract
Objectives There are limited data on the clinical and epidemiological aspects of mpox in Saudi Arabia. This study investigates the characteristics of Mpox cases from May to September 2023. Methods A total of 381 cases of Mpox were included in this study, diagnosed based on a combination of clinical symptoms and laboratory testing. Results The majority of mpox cases were males (91.1%), with a mean age of (±SD) of 32.4 (±8.3) years; 356 (93.4%) did not report travel, 277 (72.7%) denied engaging in extra-marital sex, and 379 (99.5%) were not linked to secondary cases. Fever was reported in 371 (97.4%), whereas headache was present in 314 (82.4%). Cough (1.3%) and conjunctivitis (0.5%) were rare. The most commonly affected areas in terms of lesions were the palms and soles (297 cases, 78%), followed by the genitals (206 cases, 54%), face (198 cases, 52%), and mouth (160 cases, 42%). Of the 1325 identified contacts, 1134 (85.5%) were hospital contacts, and 191 (14.5%) were community contacts, and 393 (29.6%) were high-risk contact. Of the high-risk contacts, 284 (72.3%) accepted post-exposure vaccination. The genotyped samples were all subclade IIb (formerly the West Africa clade). Conclusions This study provides valuable insights into mpox characteristics in Saudi Arabia. The genome of monkeypox virus belonged to subclade IIb of the West Africa clade. Further analysis of the global tree sublineage is needed.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | - Jaffar A. Al-Tawfiq
- Specialty Internal Medicine and Quality Department, Dhahran Health Center, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia
- Infectious Disease Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA
- Infectious Disease Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA
| |
Collapse
|
2
|
Dar NG, Alfaraj SH, Alboqmy KN, Amer H, Khanum N, Alshakrah F, Abdallah H, Kumar D, Alzarzour SH, Alzahrani NA, Arishy JY, Ahmed SA, Escorpion V, Lopez E, Jedeba S, Memish ZA. Locally acquired mpox outbreak in Riyadh, Saudi Arabia: clinical presentation, risk factors and preventive measures. J Travel Med 2023; 30:taad150. [PMID: 38006358 DOI: 10.1093/jtm/taad150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/17/2023] [Revised: 11/17/2023] [Accepted: 11/20/2023] [Indexed: 11/27/2023]
Abstract
A cluster of 16 locally acquired monkeypox cases in Riyadh, Saudi Arabia, with 10 cases reported engaging in sexual behaviour within 21 days prior to the onset of symptoms, all of whom had heterosexual contact with illegal partners within 1 week before the appearance of symptoms.
Collapse
Affiliation(s)
- Nadeem Gul Dar
- Prevention and Control of Infection Administration, King Saud Medical City, Ministry of Health, P.O. Box 2897, Riyadh 11196, Saudi Arabia
| | - Sarah H Alfaraj
- Prevention and Control of Infection Administration, King Saud Medical City, Ministry of Health, P.O. Box 2897, Riyadh 11196, Saudi Arabia
| | - Khulood N Alboqmy
- Prevention and Control of Infection Administration, King Saud Medical City, Ministry of Health, P.O. Box 2897, Riyadh 11196, Saudi Arabia
| | - Hala Amer
- Prevention and Control of Infection Administration, King Saud Medical City, Ministry of Health, P.O. Box 2897, Riyadh 11196, Saudi Arabia
- Community Medicine Research Department, National Research Center, 33 El Buhouth Street 12622, Cairo, Egypt
| | - Nazia Khanum
- Prevention and Control of Infection Administration, King Saud Medical City, Ministry of Health, P.O. Box 2897, Riyadh 11196, Saudi Arabia
| | - Faleh Alshakrah
- Prevention and Control of Infection Administration, King Saud Medical City, Ministry of Health, P.O. Box 2897, Riyadh 11196, Saudi Arabia
| | - Hassan Abdallah
- Prevention and Control of Infection Administration, King Saud Medical City, Ministry of Health, P.O. Box 2897, Riyadh 11196, Saudi Arabia
| | - Deva Kumar
- Prevention and Control of Infection Administration, King Saud Medical City, Ministry of Health, P.O. Box 2897, Riyadh 11196, Saudi Arabia
| | - Shaimaa H Alzarzour
- Prevention and Control of Infection Administration, King Saud Medical City, Ministry of Health, P.O. Box 2897, Riyadh 11196, Saudi Arabia
| | - Nojoom A Alzahrani
- Prevention and Control of Infection Administration, King Saud Medical City, Ministry of Health, P.O. Box 2897, Riyadh 11196, Saudi Arabia
| | - Jasser Y Arishy
- Prevention and Control of Infection Administration, King Saud Medical City, Ministry of Health, P.O. Box 2897, Riyadh 11196, Saudi Arabia
| | - Suhair A Ahmed
- Prevention and Control of Infection Administration, King Saud Medical City, Ministry of Health, P.O. Box 2897, Riyadh 11196, Saudi Arabia
| | - Vicenta Escorpion
- Prevention and Control of Infection Administration, King Saud Medical City, Ministry of Health, P.O. Box 2897, Riyadh 11196, Saudi Arabia
| | - Edna Lopez
- Prevention and Control of Infection Administration, King Saud Medical City, Ministry of Health, P.O. Box 2897, Riyadh 11196, Saudi Arabia
| | - Sami Jedeba
- Prevention and Control of Infection Administration, King Saud Medical City, Ministry of Health, P.O. Box 2897, Riyadh 11196, Saudi Arabia
| | - Ziad A Memish
- Prevention and Control of Infection Administration, King Saud Medical City, Ministry of Health, P.O. Box 2897, Riyadh 11196, Saudi Arabia
- Research and Innovation Center, King Saud Medical City, P.O. Box 2897, Riyadh 11196, Ministry of Health & College of Medicine, Al Faisal University, P.O. Box 50927 Riyadh 11533, Saudi Arabia
- Hubert Department of Global Health, Rollins School of Public Health, Emory University, 1518 Clifton Rd, 30322, Atlanta, GA, USA
- Division of Infectious Diseases, Kyung Hee University, Seoul 446-701, Korea
| |
Collapse
|
3
|
Zeidan RK, Shukla A, Hussein A, AlZubaidi H, Temsah MH, AlHajjaj MS, Al-Bluwi N, Awad M, Alsayed HAH, Saheb Sharif-Askari N, AlHano Z, Agha R, Hamid Q, Halwani R, Saddik B. Assessment of Knowledge, Perceptions, and Attitudes During the Global Mpox Outbreak in June 2022: A Cross-Sectional Study From the United Arab Emirates. Int J Public Health 2023; 68:1606080. [PMID: 38024212 PMCID: PMC10657881 DOI: 10.3389/ijph.2023.1606080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2023] [Accepted: 10/18/2023] [Indexed: 12/01/2023] Open
Abstract
Objectives: To examine knowledge, worry, anxiety, and vaccine acceptance for mpox among UAE adults. Methods: An online survey, advertised on academic and social media platform in June 2022 collected data from 959 participants (aged 18 and above) on mpox beliefs, risks, knowledge, worry, anxiety, COVID-19 infection, vaccination, and willingness to receive the mpox vaccine. Bivariate and logistic regression analysis identified associations and predictors between variables. Results: 56% had optimal knowledge of mpox transmission and symptoms. 54% were worried, and 27% experienced anxiety related to the outbreak. Knowledge scores were higher among women, healthcare workers, and those with reliable information sources. High perceived infection risk, changes in precautionary measures, and belief in difficult treatment predicted more worry and anxiety. Higher worry and two or more doses of the COVID-19 vaccine predicted higher likelihood of taking the mpox vaccine. Conclusion: The UAE population showed low knowledge and high worry and anxiety during the global mpox outbreak. Increasing public awareness through targeted educational campaigns is vital. Promoting better understanding of infectious diseases, addressing concerns, and encouraging vaccine uptake can prepare for future outbreaks.
Collapse
Affiliation(s)
- Rouba Karen Zeidan
- Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates
| | - Ankita Shukla
- Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates
| | - Amal Hussein
- Department of Family and Community Medicine and Behavioural Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates
| | - Hamzah AlZubaidi
- Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates
- College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates
- School of Medicine, Deakin Rural Health, Deakin University Faculty of Health, Warrnambool, VIC, Australia
| | - Mohamad-Hani Temsah
- Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia
| | - Mohamed S. AlHajjaj
- Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates
| | - Najlaa Al-Bluwi
- Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates
| | - Manal Awad
- Department of Preventive and Restorative Dentistry, College of Dental Medicine, University of Sharjah, Sharjah, United Arab Emirates
| | | | - Narjes Saheb Sharif-Askari
- Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates
- Department of Family and Community Medicine and Behavioural Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates
| | - Zahraa AlHano
- College of Medicine, University of Sharjah, Sharjah, United Arab Emirates
| | - Razan Agha
- Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates
| | - Qutayba Hamid
- Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates
- Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates
- Meakins-Christie Laboratories, Research Institute, McGill University Health Center, Montréal, QC, Canada
| | - Rabih Halwani
- Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates
- Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates
| | - Basema Saddik
- Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates
- Department of Family and Community Medicine and Behavioural Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates
- School of Population Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia
| |
Collapse
|
4
|
Zaqout A, Daghfal J, Munir W, Abdelmajid A, Albayat SS, Abukhattab M, Al-Maslamani MA. Clinical manifestations and outcome of Mpox infection in Qatar: An observational study during the 2022 outbreak. J Infect Public Health 2023; 16:1802-1805. [PMID: 37741014 DOI: 10.1016/j.jiph.2023.09.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Revised: 08/29/2023] [Accepted: 09/03/2023] [Indexed: 09/25/2023] Open
Abstract
Mpox emerged in May 2022 as a global outbreak, mostly in hitherto non-endemic countries. To describe the epidemiological and clinical characteristics of mpox in Qatar, data were retrospectively retrieved for all laboratory-confirmed mpox cases diagnosed in Qatar between May and November 2022. Twelve cases were identified; of which 10 were males, and the median age was 33.5 years (IQR 24.5-37.5). Recent sexual exposure was reported in 9 patients, 6 of which were outside Qatar. Seven individuals reported exclusive heterosexual contact. Pleomorphic skin lesions were present in all cases, with anogenital involvement in 11. Fever (7/12) and lymphadenopathy (4/12) were relatively common. All cases were HIV-negative. The majority of cases had an uncomplicated and self-limiting clinical illness. In conclusion, the majority of early mpox infections in Qatar were purportedly acquired through heterosexual contact, primarily among middle-aged men. The clinical course was mostly uneventful. In the absence of active case finding and the mild and self-limiting nature of the clinical illness, undetected community transmission cannot be ruled out.
Collapse
Affiliation(s)
- Ahmed Zaqout
- Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
| | - Joanne Daghfal
- Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
| | - Waqar Munir
- Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
| | - Alaaeldin Abdelmajid
- Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
| | - Soha S Albayat
- Department of Public Health, Ministry of Public Health, Doha, Qatar.
| | - Mohammed Abukhattab
- Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
| | - Muna A Al-Maslamani
- Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
| |
Collapse
|
5
|
Lee SS, Bockarie MJ, Al-Tawfiq JA. Was the public health emergency status of mpox ended too soon? Int J Infect Dis 2023; 134:301-302. [PMID: 37550010 DOI: 10.1016/j.ijid.2023.06.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/09/2023] Open
Affiliation(s)
- Shui-Shan Lee
- International Society for Infectious Diseases; Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Shatin, Hong Kong; S.H. Ho Research Centre for Infectious Diseases, The Chinese University of Hong Kong, Shatin, Hong Kong.
| | - Moses John Bockarie
- International Society for Infectious Diseases; School of Community Health Sciences, Njala University, Sierra Leone
| | - Jaffar A Al-Tawfiq
- International Society for Infectious Diseases; Infectious Disease Unit, Specialty Internal Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Department of Medicine, Infectious Disease Division, Indiana University School of Medicine, Indianapolis, USA; Department of Medicine, Infectious Disease Division, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| |
Collapse
|